Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Siegfried AG

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSiegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.

GDUFA

DMF Review : Complete

Rev. Date : 2025-02-13

Pay. Date : 2024-11-15

DMF Number : 40414

Submission : 2024-12-20

Status : Active

Type : II

Company Banner

Looking for Drug Master Files (DMF) for 40414 of Siegfried Ag

Looking for Drug Master Files (DMF) for 40414 of Siegfried Ag 1

20

Siegfried Ag, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Siegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.

One of their notable products is NALTREXONE, with a corresponding US DMF Number 40414.

Remarkably, this DMF maintains an Active status since its submission on December 20, 2024, highlighting commitment to regulatory compliance.

Their GDUFA DMF Review was successfully complete, with a review date of February 13, 2025, and payment made on November 15, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II